- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 239/70 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 239/70
Total number of patents in this class: 533
10-year publication summary
|
56
|
45
|
24
|
28
|
35
|
29
|
25
|
16
|
28
|
5
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 3742 |
47 |
| Array BioPharma Inc. | 551 |
23 |
| Boehringer Ingelheim International GmbH | 4629 |
20 |
| F. Hoffmann-La Roche AG | 7958 |
16 |
| Merck Sharp & Dohme LLC | 3689 |
15 |
| Duquesne University of the Holy Spirit | 136 |
14 |
| PTC Therapeutics, Inc. | 492 |
11 |
| Reata Pharmaceuticals, Inc. | 127 |
10 |
| Bristol-myers Squibb Company | 5080 |
9 |
| Janssen Pharmaceutica N.V. | 3839 |
8 |
| Tetra Discovery Partners, LLC | 12 |
8 |
| Merck Sharp & Dohme Corp. | 2247 |
7 |
| President and Fellows of Harvard College | 5792 |
7 |
| Samsung SDI Co., Ltd. | 6671 |
6 |
| Duquesne University of the Holy Ghost | 31 |
6 |
| Merck Patent GmbH | 5909 |
5 |
| The Regents of the University of Michigan | 4409 |
5 |
| Idemitsu Kosan Co., Ltd. | 3995 |
5 |
| ArQule, Inc. | 145 |
5 |
| ELC Management LLC | 1027 |
5 |
| Other owners | 301 |